CN1399917A - Cancer-resisting sausage - Google Patents

Cancer-resisting sausage Download PDF

Info

Publication number
CN1399917A
CN1399917A CN01124511A CN01124511A CN1399917A CN 1399917 A CN1399917 A CN 1399917A CN 01124511 A CN01124511 A CN 01124511A CN 01124511 A CN01124511 A CN 01124511A CN 1399917 A CN1399917 A CN 1399917A
Authority
CN
China
Prior art keywords
sausage
cancer
resisting
vitamin
sodium nitride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN01124511A
Other languages
Chinese (zh)
Inventor
陈彩玲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN01124511A priority Critical patent/CN1399917A/en
Publication of CN1399917A publication Critical patent/CN1399917A/en
Pending legal-status Critical Current

Links

Landscapes

  • Meat, Egg Or Seafood Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Conventionally the sodium nitride is used as preservative for sausage meat, and in the interior of human body the sodium nitride can be formed into amine nitrite which is a carcinogenic substance. Said invented "cancer-preventing sausage" can prevent the formation of amine nitrite. It is characterized by that in the production of sausage the proper quantity of vitamin C is added.

Description

Cancer-resisting sausage
Pork in the sausage is normally made anticorrisive agent with natrium nitrosum.This anticorrisive agent combines with amine in the meat proteins in stomach, forms nitrosamine, and this is a kind of carcinogenic substance.And vitamin C can hinder nitrite and combines with amine, thereby suppresses the formation of nitrosamine.
The present invention's " cancer-resisting sausage " is when the system sausage, adds appropriate vitamin C in sausage.
Because vitamin C can hinder nitrite and combines with amine, vitamin C can stop anticorrisive agent natrium nitrosum in the sausage to combine with amine in the meat proteins in stomach, thus the formation of resistance nitrosamine.

Claims (1)

1. sausage, it is characterized in that: the batching of this sausage has vitamin C.
CN01124511A 2001-07-27 2001-07-27 Cancer-resisting sausage Pending CN1399917A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN01124511A CN1399917A (en) 2001-07-27 2001-07-27 Cancer-resisting sausage

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN01124511A CN1399917A (en) 2001-07-27 2001-07-27 Cancer-resisting sausage

Publications (1)

Publication Number Publication Date
CN1399917A true CN1399917A (en) 2003-03-05

Family

ID=4665713

Family Applications (1)

Application Number Title Priority Date Filing Date
CN01124511A Pending CN1399917A (en) 2001-07-27 2001-07-27 Cancer-resisting sausage

Country Status (1)

Country Link
CN (1) CN1399917A (en)

Similar Documents

Publication Publication Date Title
WO2002096363A3 (en) Method for treating fibrotic diseases or other indications
MX2007003013A (en) Bicyclic amides as kinase inhibitors.
WO2003099771A3 (en) Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
ZA200004569B (en) Infusion of liquids into the human or animal body.
WO2009034315A3 (en) Vaccine
CU23260B7 (en) MOXIFLOXACINE PHARMACEUTICAL PREPARATION
CA2396865A1 (en) Farnesyl protein transferase inhibitors for treating breast cancer
WO2006071952A3 (en) Compositions and methods for improving kidney function
EP1614675A3 (en) Amino acids with affinity for the alpha-2-delta protein
WO2007118963A3 (en) Substituted n-(phenethyl)benzamide derivatives, preparation and uses thereof
PL364598A1 (en) Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
WO2003048205A3 (en) Novel proteins with il-6 inhibiting activity
WO2004091591A3 (en) Nutritional or therapeutic composition containing the compound oleuropeine or one of the derivatives thereof
WO2002062304A3 (en) Cosmetic and/or pharmaceutical agents containing an acylated amino acid and a protein condensate
WO2002096348A3 (en) Product comprising mikanolide, dihydromikanolide or an analogue thereof combined with another anti-cancer agent for therapeutic use in cancer treatment
WO2004039326A3 (en) Propofol with cysteine
MX2007003633A (en) Activated globular protein and its use in edible compositions.
BR0313031A (en) Spicy particle, food product, process for the preparation of a particle and use of a spicy particle
CN1399917A (en) Cancer-resisting sausage
MXPA02012857A (en) Use of a formulation made of or containing at least one dissimilated milk serum.
MXPA04002594A (en) Composition comprising cysteamine for improving lactation in dairy animals.
WO2004006830A3 (en) Use of ccn protein family members for the treatment of disorder associated to an altered calcium and/or sodium flux
WO2002054881A3 (en) The use of food and drink as a delevery system for phytase in humans
PT1460084E (en) Novel peptide sy
WO2001068676A3 (en) Lhrh-antagonists, production and use thereof as medicament

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication